Our high-specificity discovery proteomics methods are built to align with your coverage and throughput needs, and optimized for your sample type.
Measuring 10,000+ protein groups in diverse FFPE tissue and tumor samples – with exceptional reproducibility, and at scale.
Leveraging state-of-the-art mass spectrometry, our discovery proteomics methods deliver high-confidence annotations of proteins and their isoforms while optimizing for coverage and throughput to best suit your study requirements at each phase.
These methods are optimized to interrogate thousands of proteins per sample and include:
Measure of 12,000+ protein groups including tumor antigens and intracellular proteins.
Quantitative measure of 10,000+ proteins groups including phospho- and glyco-proteins & isoforms.
Measure of 5,400+ protein groups with exceptional reproducibility (~5% CV).
Profiling of 3,600+ protein groups including known targets of CNS disease.
Measure of 6,000+ protein groups to non-invasively probe systemic health.
Sapient can capture biologically significant signals in the low abundance proteome using nanoparticle enrichment to simultaneously deplete high abundant proteins and enrich low abundant proteins.
Our data science team can provide integrative analysis of proteomics data with the metabolomics data we generate as well as with genomics, phenotype information, and clinical inputs to elucidate protein biomarkers and their involvement in the dynamic processes underlying disease and drug response.
We do this by leveraging our DynamiQ™ Insights Engine to perform at-scale analyses that elucidate:
Use the form to request proteomics services. If you have questions, we encourage you to meet with our team.
"*" indicates required fields
